4) context is really important to your brain with psychoactive drugs, and this is as true for CBD as it is for prescription drugs that affect the serotonin cycle like stimulants and SSRIs. If you’re using CBD to target serotonin in order to have a productive workday, for example, make sure you use the CBD vape right before you sit down to work, and don’t hit it when you’re going out or watching TV.
My husband and I both think that opiates are by far a more effective pain reliever. By the by, poppy seeds (of the papaver somniferum strain) are legal in most states and grow in nearly any climate. It’s VERY easy (but also very illegal) to extract “the good stuff”. You can find directions for “poppy tea” online. I have heard it’s VERY effective for pain (similar, if not stronger, than hydrocodone).
A colleague of Mechoulam’s, Marc Feldman at Imperial College, London, tested CBD on mice that had a version of rheumatoid arthritis. He found that CBD reduced the mice’s inflammation by 50% at the right dosage. Cardiologists working with the mice at Hebrew University have found that a dosage of CBD immediately following a heart attack can reduce infarct size by about 66%.
Heather Vaughan is an Ayurvedic practitioner and writer. She spent many years struggling with Ankylosing Spondylitis (an autoinflammatory disorder which attacks the spine). Her quest for health has become a deep, respectful study of traditional medicine which as taken her all over the world. A Northern California native, Heather now resides in Santa Fe, New Mexico, where she happily dances, climbs rocks and helps other transform illness into health.
Whereas Michigan already had medical weed legalized to make for a quicker route to starting full legislation, these states don't yet have an operational system in place. North Dakota and West Virginia also still are not operational yet, nor in Louisiana or Arkansas. Ohio is also behind schedule, having been unable to meet their goal of having operational dispensaries two years after voting for legalization. And until those are operational, the Ohio Board of Pharmacy ruled that any CBD products not sold in dispensaries licensed by the state's program are illegal.
The glutamatergic system is integral to development and maintenance of neuropathic pain, and is responsible for generating secondary and tertiary hyperalgesia in migraine and fibromyalgia via NMDA mechanisms (Nicolodi et al 1998). Thus, it is important to note that cannabinoids presynaptically inhibit glutamate release (Shen et al 1996), THC produces 30%–40% reduction in NMDA responses, and THC is a neuroprotective antioxidant (Hampson et al 1998). Additionally, cannabinoids reduce hyperalgesia via inhibition of calcitonin gene-related peptide (Richardson et al 1998a). As for Substance P mechanisms, cannabinoids block capsaicin-induced hyperalgesia (Li et al 1999), and THC will do so at sub-psychoactive doses in experimental animals (Ko and Woods 1999). Among the noteworthy interactions with opiates and the endorphin/enkephalin system, THC has been shown to stimulate beta-endorphin production (Manzanares et al 1998), may allow opiate sparing in clinical application (Cichewicz et al 1999), prevents development of tolerance to and withdrawal from opiates (Cichewicz and Welch 2003), and rekindles opiate analgesia after a prior dosage has worn off (Cichewicz and McCarthy 2003). These are all promising attributes for an adjunctive agent in treatment of clinical chronic pain states.